MONALISA references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
Monalisa PN
Monalisa PN is a polynucleotide dermal filler by Monalisa, formulated for soft tissue augmentation. It is suitable for professionals restoring facial lipoatrophy. The product contains stabilized polynucleotides at 20 mg/mL with 0.3% lidocaine and is intended for professional use only.
主なメリット: Monalisa PN
- Supports soft-tissue augmentation
- Helps restore facial lipoatrophy
- Contains stabilized polynucleotides (PN) for tissue support
- Includes 0.3% lidocaine to improve injection comfort
- For professional intradermal injection
適応と専門的な使用
主な適応
- Facial lipoatrophy
- Soft tissue augmentation
- Facial tissue restoration
- Intradermal aesthetic correction
専門的な使用
Professional use: For use by licensed medical professionals only, following clinical assessment. Intended for intradermal injection only. Contraindications: Known hypersensitivity to sodium polynucleotide, lidocaine, or other amide-type anaesthetics. Allergic, autoimmune or sarcoid granulomatous disease, or endocarditis. Bleeding disorders, or use of thrombolytic agents, aggregation inhibitors, NSAIDs, anticoagulants or immunosuppressants. Pregnancy or breastfeeding. Patients under 18. Professional-use restrictions: Do not inject into blood vessels. Do not inject where another manufacturer's product is present, or where a non-biodegradable implant is already present.
施術部位
- Face
- Facial lipoatrophy-affected areas
- Soft tissue restoration areas
対象となる患者
Suitable for adult patients (18+) presenting with facial lipoatrophy or soft tissue volume loss appropriate for intradermal polynucleotide correction, as determined by the treating practitioner. Not suitable for pregnant or breastfeeding patients, or those meeting any contraindication above.
作用の仕組み: Monalisa PN
Monalisa PN works through stabilized polynucleotides (20 mg/mL) that support soft-tissue augmentation and restoration in areas affected by facial lipoatrophy, with 0.3% lidocaine for injection comfort. It is intended for intradermal aesthetic correction and facial tissue restoration in patients over 18.
Allparaで注文する理由
Allparaは、正規品で検証済みの MONALISA 製品を厳選されたサプライヤーから提供し、完全なロットトレーサビリティと専門家によるサポートを備えています。CE認証製品、EU倉庫からのEU全域への迅速な配送、競争力のある業務用価格で、クリニックと美容医療の専門家にサービスを提供しています。私たちが重視するのは患者様の安全、満足、そして結果です。安心してご利用いただけるよう、専任のアフターサポートをご用意しています。
よくある質問
What is Monalisa PN?
Monalisa PN is an injectable polynucleotide dermal filler with lidocaine manufactured by GENOSS Co., Ltd. It is a sterile, transparent gel of stabilized polynucleotides containing 0.3% lidocaine.
Is Monalisa PN biodegradable?
Yes. Monalisa PN is a bio-absorbable gel that is gradually absorbed by the body. The duration varies according to individual factors and treatment-related variables.
その他の製品: GENOSS
Clinic alternatives
Pick up where you left off
Monalisa PN
Monalisa PN is a polynucleotide dermal filler by Monalisa, formulated for soft tissue augmentation. It is suitable for professionals restoring facial lipoatrophy. The product contains stabilized polynucleotides at 20 mg/mL with 0.3% lidocaine and is intended for professional use only.
主なメリット: Monalisa PN
- Supports soft-tissue augmentation
- Helps restore facial lipoatrophy
- Contains stabilized polynucleotides (PN) for tissue support
- Includes 0.3% lidocaine to improve injection comfort
- For professional intradermal injection
適応と専門的な使用
主な適応
- Facial lipoatrophy
- Soft tissue augmentation
- Facial tissue restoration
- Intradermal aesthetic correction
専門的な使用
Professional use: For use by licensed medical professionals only, following clinical assessment. Intended for intradermal injection only. Contraindications: Known hypersensitivity to sodium polynucleotide, lidocaine, or other amide-type anaesthetics. Allergic, autoimmune or sarcoid granulomatous disease, or endocarditis. Bleeding disorders, or use of thrombolytic agents, aggregation inhibitors, NSAIDs, anticoagulants or immunosuppressants. Pregnancy or breastfeeding. Patients under 18. Professional-use restrictions: Do not inject into blood vessels. Do not inject where another manufacturer's product is present, or where a non-biodegradable implant is already present.
施術部位
- Face
- Facial lipoatrophy-affected areas
- Soft tissue restoration areas
対象となる患者
Suitable for adult patients (18+) presenting with facial lipoatrophy or soft tissue volume loss appropriate for intradermal polynucleotide correction, as determined by the treating practitioner. Not suitable for pregnant or breastfeeding patients, or those meeting any contraindication above.
作用の仕組み: Monalisa PN
Monalisa PN works through stabilized polynucleotides (20 mg/mL) that support soft-tissue augmentation and restoration in areas affected by facial lipoatrophy, with 0.3% lidocaine for injection comfort. It is intended for intradermal aesthetic correction and facial tissue restoration in patients over 18.
Allparaで注文する理由
Allparaは、正規品で検証済みの MONALISA 製品を、完全なロットトレーサビリティ、CE認証在庫、EU全域への迅速な配送、専門的なアフターサポートとともに提供しています。
よくある質問
What is Monalisa PN?
Monalisa PN is an injectable polynucleotide dermal filler with lidocaine manufactured by GENOSS Co., Ltd. It is a sterile, transparent gel of stabilized polynucleotides containing 0.3% lidocaine.
Is Monalisa PN biodegradable?
Yes. Monalisa PN is a bio-absorbable gel that is gradually absorbed by the body. The duration varies according to individual factors and treatment-related variables.